Influence of lepirudin, argatroban, and melagatran on prothrombin time and additional effect of oral anticoagulation.
D000284:Administration, Oral; D000925:Anticoagulants / Q000494:pharmacology*; D001120:Arginine / Q000031:analogs & derivatives; D001384:Azetidines; D001596:Benzylamines; D004357:Drug Synergism; D005998:Glycine / Q000031:analogs & derivatives* / Q000494:pharmacology*; D006629:Hirudins / Q000031:analogs & derivatives / Q000494:pharmacology*; D006801:Humans; D010644:Phenprocoumon / Q000008:administration & dosage / Q000494:pharmacology*; D010875:Pipecolic Acids / Q000494:pharmacology*; D011517:Prothrombin Time; D011994:Recombinant Proteins / Q000494:pharmacology*; D013449:Sulfonamides
D000925:Anticoagulants; D001384:Azetidines; D001596:Benzylamines; D006629:Hirudins; D010875:Pipecolic Acids; D011994:Recombinant Proteins; D013449:Sulfonamides; C109573:melagatran; D001120:Arginine; C031942:argatroban; D010644:Phenprocoumon; D005998:Glycine; C083544:lepirudin